1例2型糖尿病合并复杂性尿路感染不合理用药分析  

Analysis of Unreasonable Dug Use in One Case of Type 2 Diabetes with Complicated Urinary Tract Infection

作　　者：郭金娟[1] 孙增先[2] 荆莉[3] 

机构地区：[1]南京医科大学康达学院,江苏连云港222000 [2]连云港市第一人民医院药学部 [3]南京医科大学附属南京医院药学部

出　　处：《中国药师》2017年第10期1828-1830,共3页China Pharmacist

摘　　要：目的:对1例不合理用药病例进行分析,促进临床合理用药。方法:针对1例2型糖尿病合并复杂性尿路感染不合理用药,分析治疗方案,总结不合理用药的原因及如何避免临床不合理用药。结果:本例患者初始治疗选择莫西沙星不合理,且无联合用药指征。临床药师参与查房,及时与临床医生沟通,纠正不合理用药。结论:莫西沙星由于耐药性、药动学特点及不良反应等,不用于复杂性尿路感染的抗感染治疗。临床药师应为患者提供个体化治疗方案,促进临床合理用药。Objective：To analyze one case of unreasonable drug use to promote reasonable drug use in clinics. Methods： The treatment regimen with irrational drug use for one case of type 2 diabetes with complicated urinary tract infection were analyzed, and the reasons for the irrationality were summarized and some suggestions for avoiding unreasonable drug use were put forward. Results：The choice of moxifloxacin in the initial treatment was irrational, and no combination indications were shown. Clinical pharmacists partici-pated in the ward rounds and timely communicated with the clinicians to correct the drug use. Conclusion：Due to the drug resistance, pharmacokinetic characteristics and adverse reactions, moxifloxacin is unsuitable for the anti-infection treatment of complicated urinary tract infection. Clinical pharmacists should provide individualized treatment for patients to improve the effectiveness of drug therapy.

关 键 词：2型糖尿病 尿路感染 莫西沙星 

分 类 号：R97[医药卫生—药品]